These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2860658)

  • 21. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
    Ulrich S; Sandmann U; Genz A
    Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tardive dyskinesia in the aged. Duration of treatment relationships.
    Toenniessen LM; Casey DE; McFarland BH
    Arch Gen Psychiatry; 1985 Mar; 42(3):278-84. PubMed ID: 2858189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and epidemiologic aspects of tardive dyskinesia.
    Baldessarini RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Focus on lower risk of tardive dyskinesia with atypical antipsychotics.
    Nasrallah HA
    Ann Clin Psychiatry; 2006; 18(1):57-62. PubMed ID: 16517454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ten year outcome of tardive dyskinesia during continuous treatment with first generation antipsychotics.
    Rittmannsberger H
    Psychiatr Danub; 2008 Dec; 20(4):461-5. PubMed ID: 19011586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of and risk factors for tardive dyskinesia in a Xhosa population in the Eastern Cape of South Africa.
    Patterson BD; Swingler D; Willows S
    Schizophr Res; 2005 Jul; 76(1):89-97. PubMed ID: 15927802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
    Li CR; Chung YC; Park TW; Yang JC; Kim KW; Lee KH; Hwang IK
    World J Biol Psychiatry; 2009; 10(4 Pt 3):919-24. PubMed ID: 19995222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression.
    Blumberger DM; Mulsant BH; Kanellopoulos D; Whyte EM; Rothschild AJ; Flint AJ; Meyers BS
    J Clin Psychopharmacol; 2013 Jun; 33(3):391-7. PubMed ID: 23609383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The natural history of tardive dyskinesia.
    Gardos G; Cole JO; Haskell D; Marby D; Paine SS; Moore P
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):31S-37S. PubMed ID: 2906068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of tardive dyskinesia with donepezil: a pilot study.
    Caroff SN; Campbell EC; Havey J; Sullivan KA; Mann SC; Gallop R
    J Clin Psychiatry; 2001 Oct; 62(10):772-5. PubMed ID: 11816865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dyskinesia and neuroleptic exposure in elderly psychiatric inpatients.
    Sweet RA; Mulsant BH; Rifai AH; Zubenko GS
    J Geriatr Psychiatry Neurol; 1992; 5(3):156-61. PubMed ID: 1353963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analogue functional analysis of movements associated with tardive dyskinesia.
    Valdovinos MG; Roberts C; Kennedy CH
    J Appl Behav Anal; 2004; 37(3):391-3. PubMed ID: 15529895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.
    Morgenstern H; Glazer WM
    Arch Gen Psychiatry; 1993 Sep; 50(9):723-33. PubMed ID: 8102845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The course of tardive dyskinesia in patients on long-term neuroleptics.
    Bergen JA; Eyland EA; Campbell JA; Jenkings P; Kellehear K; Richards A; Beumont PJ
    Br J Psychiatry; 1989 Apr; 154():523-8. PubMed ID: 2574069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tardive dyskinesia, clozapine, and treatment response.
    Dalack GW; Becks L; Meador-Woodruff JH
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):567-73. PubMed ID: 9682273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tardive dyskinesia in an outpatient population: prevalence and predisposing factors.
    Yassa R; Ananth J; Cordozo S; Ally J
    Can J Psychiatry; 1983 Aug; 28(5):391-4. PubMed ID: 6138143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study of tardive dyskinesia in Japan.
    Inada T; Ohnishi K; Kamisada M; Matsuda G; Tajima O; Yanagisawa Y; Hashiguchi K; Shima S; Oh-e Y; Masuda Y
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(4-5):250-4. PubMed ID: 1675874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tardive dyskinesia in elderly psychiatric patients in Singapore.
    Tan CH; Tay LK
    Aust N Z J Psychiatry; 1991 Mar; 25(1):119-22. PubMed ID: 1675562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis.
    Carbon M; Hsieh CH; Kane JM; Correll CU
    J Clin Psychiatry; 2017 Mar; 78(3):e264-e278. PubMed ID: 28146614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tardive dyskinesia presenting as a psychosis.
    Asnis GM; Nathan RS; Davies SO; Halbreich U
    J Nerv Ment Dis; 1979 Dec; 167(12):762-3. PubMed ID: 41884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.